VECCHIO, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 718
EU - Europa 394
AS - Asia 343
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
AF - Africa 1
Totale 1.462
Nazione #
US - Stati Uniti d'America 690
IT - Italia 264
SG - Singapore 240
CN - Cina 69
SE - Svezia 39
DE - Germania 33
CA - Canada 28
GB - Regno Unito 19
KR - Corea 9
FR - Francia 8
HK - Hong Kong 8
IN - India 7
NL - Olanda 7
CZ - Repubblica Ceca 5
JP - Giappone 4
RU - Federazione Russa 4
UA - Ucraina 4
ES - Italia 3
RO - Romania 3
BR - Brasile 2
EU - Europa 2
IR - Iran 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
DK - Danimarca 1
FI - Finlandia 1
GR - Grecia 1
MN - Mongolia 1
MY - Malesia 1
PT - Portogallo 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 1.462
Città #
Chandler 140
Singapore 104
Catanzaro 59
Santa Clara 53
Milan 49
Lawrence 44
Princeton 44
Seattle 27
Ottawa 26
Boardman 24
Wilmington 23
Ashburn 18
London 17
Des Moines 14
Munich 14
Cosenza 11
Napoli 11
Chicago 9
Hong Kong 8
Foggia 7
Augusta 6
Norwalk 6
Olomouc 5
Redmond 5
Beijing 4
Caserta 4
Hanover 4
Latina 4
Los Angeles 4
Marano 4
Paris 4
Shanghai 4
Taranto 4
West Jordan 4
Xi'an 4
Ferrara 3
Pune 3
Redwood City 3
Reggio Calabria 3
Rome 3
Adrano 2
Assago 2
Aversa 2
Bagnara Calabra 2
Belgrade 2
Clifton 2
Dalian 2
Dalmine 2
Edmonton 2
Gallipoli 2
Genoa 2
Guangzhou 2
Hangzhou 2
Jiaxing 2
Mapo-gu 2
Milazzo 2
Montalto Uffugo 2
Mugnano di Napoli 2
Naples 2
Omaha 2
Phoenix 2
Romainville 2
San Francisco 2
Seoul 2
Settingiano 2
Shenzhen 2
Songpa-gu 2
Suseong-gu 2
São Paulo 2
Timisoara 2
Torre Del Lago 2
Vibo Valentia 2
Wuhan 2
Amsterdam 1
Ardabil 1
Athens 1
Bogen 1
Boston 1
Cava Dei Tirreni 1
Cheongju-si 1
Clearwater 1
College Station 1
Council Bluffs 1
Dallas 1
Foshan 1
Fremont 1
Fuzhou 1
Giarre 1
Gioia Tauro 1
Haining 1
Helsinki 1
Heyuan 1
Houston 1
Josho 1
Kuala Lumpur 1
Las Vegas 1
Leawood 1
Lisbon 1
Madrid 1
Milwaukee 1
Totale 876
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 99
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 67
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 54
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 44
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 44
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 43
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 41
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 40
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 40
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 39
Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65 38
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 38
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder 37
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 36
A novel phage display based platform for exosome diversity characterization 36
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 35
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 35
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 35
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 32
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 31
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 31
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 30
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 30
Crucial role for IBtk in the survival and maintenance of mature B cells 30
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 30
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 28
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 28
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 27
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 26
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 26
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 26
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 26
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 25
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 25
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 24
Insights into Thymus Development and Viral Thymic Infections 24
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 24
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 24
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 24
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 23
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 22
The Double-Edged Sword of Oleuropein in Ovarian Cancer Cells: From Antioxidant Functions to Cytotoxic Effects 18
Iron affects the sphere-forming ability of ovarian cancer cells in non-adherent culture conditions 16
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 15
Revisiting Bacterial Ubiquitin Ligase Effectors: Weapons for Host Exploitation 12
Mass Spectrometry-Based Identification of a Tumor Sialoglycoprotein Antigen involved in Cancer Progression 11
The Inhibitor Of Bruton’ Tyrosine Kinase-G Regulates The Btk Signaling In B Cells 11
Influence of fibroblasts on mammary gland development, breast cancer microenvironment remodeling, and cancer cell dissemination 11
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 9
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 8
Exploring the effects of paclitaxel-loaded zein nanoparticles on human ovarian carcinoma cells 6
null 6
Totale 1.540
Categoria #
all - tutte 18.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 0 0 0 0 0 0 5 30
2020/2021116 11 6 2 4 8 8 10 1 30 28 0 8
2021/2022175 6 0 5 39 7 8 9 46 11 19 23 2
2022/2023420 90 21 31 16 48 26 7 40 77 26 29 9
2023/2024227 41 22 16 9 10 53 21 11 3 7 7 27
2024/2025505 94 29 28 26 75 80 20 22 106 24 1 0
Totale 1.540